KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹681 Cr | ₹630 Cr | ₹615 Cr | ₹551 Cr | ₹478 Cr |
What is the latest Revenue of KOPRAN ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹681 Cr |
| Mar2025 | ₹630 Cr |
| Mar2024 | ₹615 Cr |
| Mar2023 | ₹551 Cr |
| Mar2022 | ₹478 Cr |
How is Revenue of KOPRAN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹681 Cr | 8.23 | |
| Mar2025 | ₹630 Cr | 2.44 | |
| Mar2024 | ₹615 Cr | 11.54 | |
| Mar2023 | ₹551 Cr | 15.38 | |
| Mar2022 | ₹478 Cr | - | |
Compare Revenue of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹833.2 Cr | -9.4% | -16.9% | 8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -9.4% |
-16.9% |
8.5% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses